MUSTANG BIO, INC. Cash
MUSTANG BIO, INC. (MBIO) had Cash of $75.01 million as of 2017-03-31, per its 10-Q filed 2017-05-15.
Discontinued › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:Cash · last filed 2017-05-15
- 2017-03-31: Cash $75.01M.
- 2016-12-31: Cash $27.50M.
- 2016-09-30: Cash $11.12M.
- 2016-03-31: Cash $0.00.
| Period end | Cash |
|---|---|
| 2017-03-31 | $75.01M 10-Q · filed 2017-05-15 |
| 2016-12-31 | $27.50M 10-Q · filed 2017-05-15 |
| 2016-09-30 | $11.12M 10-Q · filed 2016-11-14 |
| 2016-03-31 | $0.00 10-Q · filed 2017-05-15 |
| 2015-12-31 | $0.00 10-Q · filed 2017-05-15 |
| 2015-09-30 | $0.00 10-Q · filed 2016-11-14 |
| 2015-03-12 | $0.00 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |